Leadership
Dr. Mukesh Kumar, PhD, RAC, CEO and Founder Brij Strategic Consultations (FDAMap.com)
Dr. Mukesh Kumar is CEO and Founder
Dr. Mukesh Kumar is CEO and Founder of FDAMap, a Washington DC-based firm helping manufacturers and developers of FDA-regulated products in regulatory affairs, quality assurance, clinical trials and smart development strategies. His key expertise is in global regulatory project management, regulatory submissions, compliance inspections, operational management, supply management, clinical operations, and multi-national project management for medicinal and diagnostic products. He has led clinical development of more than 100 products over the last 20 years.
He has been a leader in more than 150 clinical trials in about 34 countries including countries in the EU, Taiwan, Korea, Japan, China, Canada, countries in South America, Australia, and India. He has led more than 100 GCP, GLP, GMP and GACP audits in the US and several countries in Europe, North and South Americas and Asia in the last 15 years. He has conducted numerous training workshops in FDA compliance related issues and has authored numerous articles in peer-reviewed journals.
His weekly blog, FDA Puran, is subscribed by over 80,000 readers globally. He is also the Professor (Adjunct), Regulatory Sciences, at the School of Medicine, George Washington University, Washington DC. Dr. Kumar is a PhD in Biochemistry and a certified regulatory professional by the Regulatory Affairs Professionals Society, USA.
Our Core Values
Our Comprehensive Clinical Trial Design and
Planning Services
We offer a complete range of services tailored to meet your unique needs:
Protocol and Informed Consent Form (ICF) Development
Site Selection and Feasibility Studies
Institutional Review Board (IRB)/Independent Ethics Committee (IEC) Approval
Clinical Trial Risk Assessment and Mitigation Plans
Ready to Begin?
Let us help you design and plan your clinical trial with confidence.
Ensure seamless trial execution with expert protocol development, site selection, regulatory approvals, and risk mitigation strategies tailored to your study needs.
Protocol and Informed Consent Form (ICF) Development
- Creation of detailed, compliant clinical trial protocols that meet regulatory standards while prioritizing patient safety and trial efficiency.
- Development and review of clear, patient-centric ICFs to ensure participants fully understand the trial and its potential risks.
- Guidance on clinical trial protocol amendments to address emerging trial needs or regulatory feedback.
Site Selection and Feasibility Studies
- Comprehensive feasibility assessments to evaluate trial viability based on your therapeutic area and target population.
- Identification and selection of optimal trial sites, focusing on patient recruitment potential, site expertise, and past performance.
Institutional Review Board (IRB)/Independent Ethics Committee (IEC) Approval
- Preparation and submission of all required documents to secure timely IRB/IEC approval.
- Expert consultation to navigate ethical considerations and address potential regulatory hurdles.
Clinical Trial Risk Assessment and Mitigation Plans
- Identification of potential risks at every stage of your clinical trial.
- Development of robust risk mitigation strategies to ensure trial continuity and regulatory compliance.
- Ongoing monitoring and adaptation of risk plans as your trial progresses.
Why Choose
FDAMap Clinical?
Partner with a Trusted CRO for Regulatory Excellence and Trial Success
Efficiency and Precision
From protocol development to clinical trial site selection, our services are designed to streamline clinical trials process while maintaining the highest standards of quality.
Tailored Solutions
We customize our approach to your trial’s specific needs, therapeutic area, and target population.
Regulatory Expertise
Our team brings decades of experience in regulatory compliance to ensure your trial meets all requirements.